when did tirzepatide come out What Is Used for? Approved and Potential Uses Eli Lilly launches weight-loss drug

The FDA has not yet removed the semaglutide drugs from its shortage list

Heres a brief overview of some key agents used in the treatment of prostate cancer: Pembrolizumab (Keytruda) How It Works : Pembrolizumab targets the PD-1 (programmed death-1) receptor on T-cells, preventing cancer cells from using the PD-L1 protein to evade immune detection

Practical Recommendations for Clinicians Given the inconclusive data on bone safety during GLP1 treatment, clinicians should: Assess fracture risk using tools like FRAX before starting therapy Order BMD tests for patients with osteoporosis risk factors Monitor for excessive or rapid weight loss that may compromise bone mass Promote calcium and vitamin D intake, resistance training, and fall prevention strategies Refer to endocrinologists or bone specialists as needed for complex cases Future Research Questions Several questions remain unanswered about how GLP1 medications influence longterm bone integrity: Do individual GLP1 agents differ in their effects on bone remodeling

Driving the news: Under current law, Medicare is barred from covering drugs for weight loss

Discussion topics included: Nutrition and adequate protein intake Strength training and preserving muscle mass Bone density and long-term health Sleep and stress management Building sustainable habits beyond rapid weight loss Tim Heath highlighted the importance of viewing GLP-1 medications as part of a broader health strategy rather than a standalone solution

Ozempic Ozempic contains the same active ingredient (semaglutide) found in Wegovy and compounded semaglutidethe difference lies in FDA indication, branding, and dosing